The BaBy Blissfu Myopia Treatment Instrument emits low-energy, high-brightness, safe red light of specific wavelengths through the main unit of the product to irradiate the fundus. This can improve the blood and oxygen supply to the choroid of the fundus, promote the growth and thickening of the choroid, thereby inhibiting the growth of the axial length and effectively delaying the progression of myopia.

Core advantages:

(1) Quadruple protection, 10 times safety redundancy, and comprehensive safety guarantee: far exceeding international authoritative safety standards; millisecond-level emergency response, safe and reliable;

(2) Ten-step parameter chain optical path design, efficient axis and degree control: golden wavelength, effectively suppressing ocular axial growth; uniform irradiance spot illuminating the macula lutea of the fundus, better achieving the PBM effect;

(3) Clinically verified prevention and control effect: Numerous clinical studies on previous generation products have confirmed the effectiveness of red light irradiation. Preliminary research data on the new generation product indicates that Beibeile effectively delays the growth of the ocular axis, promotes choroidal thickening, and further controls the increase in refractive power;

(4) Intelligent and interconnected ecosystem: digital management of equipment and usage process;

(5) Minimalist experience, easy to adhere to: Handheld and convenient design, ready to use upon startup; only 2 times of 3-minute irradiation per day, making it easier to adhere to